Keith Blackwell

Wonderful article about Emily Knight and the whole The Engine Accelerator team on the amazing work their doing changing the world with #ToughTech!

28

If you enjoyed our first blog on the metrics that matter for Verticalized SaaS then don't miss on the Part II of the series where my colleagues Devraj Hom Roy and Matt Schaar discuss the strategic and operational choices to improve these operational indicators. https://lnkd.in/g5QkCrcH

15

1 条评论

Series A or B wondering when to bring in a VP of Finance or CFO? It’s a crucial decision that can shape the future of your company. At this stage, financial leadership is not just about managing numbers but also scaling processes, securing funding, and driving strategic growth. My colleague Paul breaks down key signs that it’s time to hire and indicators for choosing between VP of Finance and a CFO #FinanceLeadership #CFO #StartupGrowth #SeriesA #SeriesB #NextGenLeadership

6

Programmatic #M&A can help companies build resiliency, but this approach to deal making requires a solid game plan—one that will guide proactive deal sourcing and opportunistic deal evaluation. #privateequity #valuecreation https://ow.ly/3nT950QKBIG

3

Our partner Eddie Eltoukhy has identified these opportunities in Biotech. Eddie has a PhD in bioengineering from Massachusetts Institute of Technology and over a decade experience as an operator. Reach out to him if you are working on these areas of biotech. Pear VC - Technology-Driven Therapeutic Platforms Companies developing therapeutic assets with a core product engine Proprietary tool, workflow, or samples leading to novel biological data sets Preference for omics platforms or high throughput screening / engineering workflows First-in-class or best-in-class drugs - Next-Generation Therapeutic Modalities Technologies to improve the efficacy, safety, access, or reach of next-gen modalities including the following: Genomic medicines (gene tx & gene editing) Cell therapies Targeted protein degraders Antibody-drug conjugates Radiopharma - Precision Medicine New technologies supporting the discovery of novel biomarkers and the generation of proprietary data sets for applications in: Disease screening Therapy selection Recurrence monitoring - Life Sciences + AI Software Platforms Software & AI-driven platforms to improve all aspects of life sciences R&D, including: Target discovery and validation Drug design and optimization Manufacturing Regulatory Clinical development

118

5 条评论

Great time on the Embracing Erosion podcast w/Devon O'Rourke! We talked about: ?? How to scale a company from concept to 9-figure exit ?? How to break away from the traditional consulting model and apply product approaches ? Why it’s important to iterate quickly and often with messaging ????What signals are important to pay attention to when investing in startups and much more!

1

1 条评论

??? On the latest episode of Embracing Erosion, Devon was joined by Alex Pattis, General Partner at Riverside Ventures and founding team member of Hampton. Alex is also the co-founder of Last Money In Media, a leading VC newsletter that explores Special Purpose Vehicles (SPVs) within the Venture Capital ecosystem. As a prominent advocate for the SPV investment format over the traditional VC fund model, Alex brings a wealth of knowledge and experience to the table. This episode dives deep into: ?? How to scale a company from concept to a 9-figure exit ?? Breaking away from the traditional consulting model and applying product approaches ? The importance of iterating quickly and often with messaging ???? Key signals to watch when investing in startups Don't miss this insightful conversation. Listen now ?? https://lnkd.in/gEKv5ghE #VentureCapital #SPVs #StartupInvesting #ProductMarketing

4

?? Calling all fundraising Boston Metro B2B tech startups! ?? Are you currently fundraising and ready to pitch in front of Boston's top angel investors and early-stage fund managers? On November 19th, Venture Lane | Startup Hub is hosting our exclusive Pitch Night ?? - a rare opportunity for Boston Metro’s early-stage B2B tech founders to present their investor pitch live and connect directly with key decision-makers in the local investment community. We’re on a mission to showcase the next wave of standout B2B tech companies from Boston. If you're ready to elevate your fundraising efforts and make meaningful connections, don't miss this opportunity. ? Apply by October 22nd to secure your spot! ?? Find the application link in the comments below. #B2BTech #Startups #Fundraising #BostonStartups #PitchNight #VentureLaneStudio

46

6 条评论

This week Mikal Ventures brings you a 4-week breakdown of the US capital market with an emphasis on the Mikal verticals. Over the 4-week period ending August 19, about 960 new companies were added, resulting in just under 97,702 companies included in the US Health Tech, Med Tech, Fin Tech, AI Tech, and Ed Tech verticals. AI Tech maintained its most active status, seeing the greatest percentage of growth in both new companies and transactions.?The US Fin Tech vertical led the way in SEC Filings and US Med Tech led in news articles. Mikal Ventures publishes these stats to provide a perspective on how the verticals and new startups move through time.?We hope you find them informative?and thought-provoking. VC Investors are always adjusting their "Play Book" with a variety of options for investing. Mikal Ventures is one of those alternatives, offering curated solutions to real world problems. Reach out if you have questions on how we can be of assistance and bookmark?https://mikalventures.com/?for additional insights and information.

1

This week Mikal Ventures brings you a 4-week breakdown of the US capital market with an emphasis on the Mikal verticals. Over the 4-week period ending September 16, 1,245 new companies were added, resulting in just under 98,450 companies included in the US Health Tech, Med Tech, Fin Tech, AI Tech, and Ed Tech verticals. US AI Tech again saw the greatest percentage growth in new companies at 30%, vs. the vertical average of 13% for the period. AI Tech also led the group in transactions and news articles. US Med Tech led in SEC Filings. Mikal Ventures publishes these stats on a rolling 4-week basis to provide a perspective on how the verticals and new startups move through time.?We hope you find them informative?and thought-provoking. VC Investors are always adjusting their "Play Book" with a variety of options for investing. Mikal Ventures is one of those alternatives, offering curated solutions to real world problems. Reach out if you have questions on how we can be of assistance and bookmark?https://mikalventures.com/?for additional insights and information.

2

2 条评论

Here's a piece from Fortune (behind a paywall) on the use of secondary transactions by VC firms. Mark Suster from Upfront Ventures notes the secondary market is emerging as a critical tool for VC's, and that VC's might need to emulate their PE peers in the use of GP-led transactions. I agree this will become more common, and in some ways, VC use of secondary transactions is a more natural fit. VC funds don’t need to maintain controlling interest, so selling partial stakes is easier. Conversely, it’s also easier for a VC firm to buy a minority stake. If exits remain muted, the need for a secondary solution will undoubtedly increase. Venture capital firms often hold anti-dilution rights during fundraises, yet many dated funds lack the capital to exercise those rights. Worse, in some situations, ‘pay to play’ rounds can threaten to zero out investments made in funds without additional investment capital. Secondary transactions offer a viable solution, allowing firms to manage their portfolios effectively, harvest value and mitigate risk. The issue has always been pricing. Secondary funds have always had much more comfort with the valuation methodology (rooted in financial performance) of private equity portfolio companies, than the valuation 'art' of venture capital. Perhaps more VC funds entering as buyers or partnering with secondary funds is the answer? #VentureCapital #SecondaryMarkets #InvestmentStrategy #Liquidity #PrivateEquity #GPLedSecondary https://lnkd.in/gM3bzTdv

6

Check us out on Substack! If you like what you see, please subscribe. More to follow!

18

2 条评论

"Using examples of successful Verticalized SaaS companies, we identified four core methods that have a marked influence on the metrics that matter:?Acquiring new customers quickly, increasing ARPU for existing customers, preventing churn, and building a capital-efficient sales engine." Alongside Devraj Hom Roy and Michael Wolfe, we're back with Part Two of our series on #vSaaS - this time, we're focused on the strategies for success, giving kudos to some of the greats in the industry who have paved pathways of growth for others to follow. We hope you enjoy it - and share widely with any investors, practitioners, or founders who would find it valuable! Amee Parbhoo Rahil Rangwala Paolo Limcaoco Ishan Mishra Sebastian Molina Gasman, CFA Jasiel Martin-Odoom Semra Ezedin Eugenia Shevchenko Katie Hallaran Jackson Pellegrini Alon Pardo Khushi Gupta

10

1 条评论

Markets talk. We listen. We've from heard from capital allocators (#VC, #PrivateEquity, #FamilyOffices....even #VentureStudios, #Incubators and #Accelerators) that due diligence is a bottleneck to deal flow. It's time-consuming, expensive and often, subjective. We've launched #VentureIQ by the 9point8 Collective to directly address this problem. VentureIQ is an AI-enabled diligence solution that provides rapid scale diligence reports with exceptional fidelity and demonstrable cost efficiency - all within a single business day. We're in our soft launch, now. So, if you want to gain back valuable time and expose the long tail of deal flow diligence, shoot me a DM or visit VentureIQ.ai.

23

1 条评论

Such an excellent conversation this week. For those in venture capital, this is a must listen. https://lnkd.in/gQUgM8q9

1

1 条评论

Episode #102 Fireside with a VC speaking with Tige Savage who cofounded Revolution with Steve Case, founder of AOL – America Online, one of the biggest internet companies in history reaching a peak market cap of $200bn dominating email, internet connectivity, online news, and chat. Tige discusses all things venture capital with a wealth of multi-decade experience covering a wide area of topics on how to run a high-performing VC fund year over year and best practices on investing, governance, legals, portfolio construction, sectors, overall strategy, and today’s exit market. Discussing the organization of Revolution with 1) Revolution Rise of the Rest – their $150m pre-seed fund, 2) Revolution Ventures – the $150m VC fund Tige manages with a concentrated 15 portfolio companies per fund, and 3) Revolution Growth which continues to invest in Series B and beyond. Discussed the pioneering thesis of investing across the US rather than being concentrated in the Silicon Valley, New York, Boston, or other highly evolved tech corridors and why Washington DC matters. Find the full episode on YouTube: https://lnkd.in/gyB-yjvG. Find this and all full episodes for Fireside with a VC on your favorite podcast platform here: https://lnkd.in/gtzuxjJh. https://revolution.com/ https://lnkd.in/gyCbq7jy https://www.7bc.vc/ https://lnkd.in/gFa_AAZ7 Join our Newsletter?- Fireside with a VC: https://subscribe.7bc.vc. Join the conversation, leave comments, and tell us what you think about these topics and this episode.

14

5 条评论

New Guest Blog Post: Investing in Haatch SEIS: An investor’s perspective Head to our blog for unique insight from Lisa Best as she provides an investor's perspective on investing with Haatch! Do reach out to Tom Healy from Haatch for further insights Fred Soneya Charlie Weavers-Wright Sophie Weavers-Wright

11

One of the things we see quite often at Grit Capital Partners, is a newly minted CEO. We see a big difference in the transition to CEO based upon the historical lane the CEO is coming from. There are different new muscles if you are coming from Product, Engineering, Finance, etc. In this article, we go deep on the CRO to CEO transition, which includes some thoughts from Rosie O'Meara, a particularly fine example of someone who has made the transition quite well. What were your biggest transition moments? https://lnkd.in/eEB-K2ZU

79

6 条评论